MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Amarin Co. plc Company Profile (NASDAQ:AMRN)

Consensus Ratings for Amarin Co. plc (NASDAQ:AMRN) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $6.75 (237.50% upside)

Analysts' Ratings History for Amarin Co. plc (NASDAQ:AMRN)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015SunTrustUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Goldman SachsReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Amarin Co. plc (NASDAQ:AMRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q116($0.11)($0.14)$26.77 million$25.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.13)($0.10)$23.62 million$26.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.12)($0.14)$21.93 million$21.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q2($0.12)($0.15)$19.10 million$17.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015Q115($0.11)($0.16)$21.86 million$15.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414($0.13)($0.11)$17.40 million$16.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.14)($0.17)$14.87 million$14.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.15)($0.14)$12.86 million$12.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014Q114($0.18)($0.16)$11.65 million$11.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.23)($0.26)$11.17 million$10.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013($0.32)($0.25)$10.25 million$8.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.38)($0.26)$5.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.39)($0.41)$5.21 million$2.34 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012($0.28)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.22)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Amarin Co. plc (NASDAQ:AMRN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)
Dividend History for Amarin Co. plc (NASDAQ:AMRN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Amarin Co. plc (NASDAQ:AMRN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016John F TheroCEOBuy25,000$1.37$34,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015John F TheroCEOBuy20,000$2.35$47,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014John F TheroInsiderBuy50,000$0.83$41,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Michael James FarrellInsiderBuy5,500$0.84$4,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Amarin Co. plc (NASDAQ:AMRN)
DateHeadline
06/24/16 02:27 PMNew Broker Ratings For Amarin Corporation PLC (AMRN) - FTSE News
06/24/16 02:27 PMAmarin Corporation plc versus Anacor Pharmaceuticals, Inc. Head to Head Compare - CML News
06/23/16 09:55 PMStrong Sell Calls Recommendations For Amarin Corporation PLC (NASDAQ:AMRN) At 0 - Investor Newswire
06/22/16 02:28 PMAmarin Corporation PLC (NASDAQ:AMRN) Analyst Rating Consensus - TheFounders Daily
06/22/16 07:17 AMBrokers Issue Average Price Target Of 3.08 On Amarin Corporation PLC (AMRN) - Fiscal Standard
06/21/16 02:26 PMAmarin Corporation plc (NasdaqGM:AMRN) Stock Momentum Hits Strength - CML News
06/20/16 02:30 PMCompany Shares of Amarin Corporation PLC Drops by -3.3% - Trade Calls
06/19/16 02:25 PMThis Weeks Broker Views For Amarin Corporation PLC (AMRN) - Fiscal Standard
06/16/16 02:27 PMCan Amarin Corporation PLC (NASDAQ:AMRN) Keep Up with Analyst Expectations? - Investor Newswire
06/15/16 07:34 PMAmarin - Vascepa Gains Protection Until At Least 2020 - Seeking Alpha
06/15/16 02:33 PMHC Stocks Indications: Pacific Biosciences of California (NASDAQ:PACB), Amarin Corporation plc (ADR) (NASDAQ ... - share market updates (press release)
06/15/16 02:33 PMEuropean ADRs Edge Higher as Diversified Mining Stocks' Gains Offset Mixed Fortunes for Pharma Companies - Nasdaq
06/15/16 07:18 AMEuropean ADRs Edge Lower as Pharma Stocks See Mixed Fortunes - Nasdaq
06/14/16 02:29 PMAmarin (NASDAQ:AMRN) reports data for Vascepa that indicated reductions in potentially atherogenic lipid parameters ... - KC Register
06/14/16 07:15 AMNoticeable Price Moves: Amarin Corporation PLC (NASDAQ:AMRN) , Great Basin Scientific, Inc. (NASDAQ:GBSN) - Street Updates
06/13/16 02:27 PMComplete Analysis of: Waste Connections Inc. (NYSE:WCN), Amarin Corporation plc (NASDAQ:AMRN) - Beacon Chronicle
06/11/16 10:09 AMVascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides - [at noodls] - June 11, 2016 BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 06/11/16 -- Amarin Corporation plc(NASDAQ: AMRN)today announced additional data on Vascepa (icosapent ethyl) presented at the annual ...
06/09/16 02:29 PMComprehensive Analysis of: Caesars Entertainment Corporation (NASDAQ:CZR), Amarin Corporation plc (NASDAQ ... - Beacon Chronicle
06/08/16 02:54 PMPrice Target Summary: Golden Minerals Company (NYSEMKT:AUMN), Amarin Corporation plc (NASDAQ:AMRN) - Beacon Chronicle
06/08/16 05:32 AMAMARIN CORP PLC\UK Files SEC form 8-K, Regulation FD Disclosure -
06/07/16 10:31 AMCompany Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) to Present Vascepa(R) Data at American Diabetes ... - Smarter Analyst
06/06/16 07:45 PMAnalyst Recommendations: Amarin Corporation plc (NASDAQ:AMRN), International Business Machines Corporation ... - Beacon Chronicle
06/06/16 12:04 PMEarnings Estimates Analysis: Amarin Corporation plc (NASDAQ:AMRN) - News Oracle
06/06/16 06:38 AMVascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific Sessions - [at noodls] - June 6, 2016 BEDMINSTER, NJ AND DUBLIN, IRELAND -- (Marketwired) -- 06/06/16 -- Amarin Corporation plc (NASDAQ: AMRN)today announced that new data related to Vascepa® (icosapent ethyl) will be presented ...
06/04/16 10:56 AMJefferies Group Reaffirms “Buy” Rating for Amarin Co. plc (AMRN) - Let Me Know About This
06/03/16 07:40 AMAmarin (AMRN) Looks Good: Stock Adds 6.7% in Session -
06/02/16 11:06 AMWhat Analysts Suggest About Amarin Corporation plc (ADR) (NASDAQ:AMRN)? - The Point Review - The Point ReviewWhat Analysts Suggest About Amarin Corporation plc (ADR) (NASDAQ:AMRN)?The Point ReviewAmarin Corporation plc (ADR) (NASDAQ:AMRN) has grabbed the attention from analysts, when it saw a value increase of 11.83 percent in the last trading session. A total of 5.43 million shares exchanged hands during the intra-day trade compared with its ...Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces FDA New Chemical Entity Market ...Smarter AnalystStock Earnings Estimates Under Consideration: Amarin Corporation plc (ADR) (NASDAQ:AMRN)CWRU ObserverStocks inside Analysts Spotlight: Amarin Corporation PLC (NASDAQ:AMRN) , Sunesis Pharmaceuticals, Inc. (NASDAQ ...Street UpdatesIs stories -share market updates (press release) -WsNews 4investorsall 19 news articles »
06/01/16 10:52 AMStock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces FDA New Chemical Entity Market ... - Smarter Analyst - The Point ReviewStock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces FDA New Chemical Entity Market ...Smarter AnalystAmarin Corporation plc (ADR) (NASDAQ:AMRN) announced that the U.S. Food and Drug Administration (FDA) has determined that Vascepa® (icosapent ethyl) capsules are eligible for five-year, new chemical entity (NCE), marketing exclusivity pursuant to ...Stock Earnings Estimates Under Consideration: Amarin Corporation plc (ADR) (NASDAQ:AMRN)CWRU ObserverStocks inside Analysts Spotlight: Amarin Corporation PLC (NASDAQ:AMRN) , Sunesis Pharmaceuticals, Inc. (NASDAQ ...Street UpdatesRevenue Forecast of Two Stocks: Amarin Corporation PLC (NASDAQ:AMRN), Arena Pharmaceuticals, Inc. (NASDAQ ...WsNews 4investorsIs stories -Share Trading News -share market updates (press release)all 15 news articles »
06/01/16 07:03 AMAmarin to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - June 1, 2016 BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 06/01/16 -- Amarin Corporation plc(NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics ...
05/31/16 12:43 PMAmarin Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) (icosapent ethyl) Capsules - [at noodls] - May 31, 2016 BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 05/31/16 -- Amarin Corporation plc(NASDAQ: AMRN)announced today that the U.S. Food and Drug Administration (FDA) has determined that ...
05/26/16 10:12 AMAmarin Corp. Plc :AMRN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/25/16 07:09 PMThe Statistics Don't Lie: Amarin Corporation plc (NASDAQ:AMRN) Earnings Preview - iStreetWire - The Statistics Don't Lie: Amarin Corporation plc (NASDAQ:AMRN) Earnings PreviewiStreetWireAmarin Corporation plc (AMRN) added 0.55% to reach at the floor price of $1.83 as the company is set to share its next quarterly earnings on August 04, 2016. AMRN stock trades between $1.77 and $1.85 before the earnings release. Let's take a closer ...
05/23/16 07:03 AMHC Stocks Movements Activity: Amarin Corporation plc (ADR) (NASDAQ:AMRN), Array Biopharma Inc (NASDAQ:ARRY) - share market updates (press release) - HC Stocks Movements Activity: Amarin Corporation plc (ADR) (NASDAQ:AMRN), Array Biopharma Inc (NASDAQ:ARRY)share market updates (press release)Shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN) ended Friday session in green amid volatile trading. The shares closed up +0.04 points or 2.38% at $1.72 with 1.35 million shares getting traded. Post opening the session at $1.69, the shares hit an ...Active Stocks on Frontline- Harman International Industries (NYSE:HAR), American Capital (NASDAQ:ACAS), Amarin ...Seneca GlobeActive Broker's Choice- Verizon Communications (NYSE:VZ), American Capital (NASDAQ:ACAS), Amarin (NASDAQ ...Street Wise Report (press release) (blog)all 3 news articles »
05/23/16 07:03 AMTraders Actions to Focus: Amarin Corporation PLC (NASDAQ:AMRN) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates - Traders Actions to Focus: Amarin Corporation PLC (NASDAQ:AMRN) , Endologix, Inc. (NASDAQ:ELGX)Street UpdatesOn 5/20/2016, Amarin Corporation PLC (NASDAQ:AMRN) ended trading session higher at $1.72 with +2.38%. The company traded a volume of 1.35 million shares as comparison to average volume of 793.7 thousand shares. During the 52 –week period, the ...and more »
05/21/16 12:20 AMStock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Poster Presentation At National Lipid ... - Smarter Analyst - Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Poster Presentation At National Lipid ...Smarter AnalystAmarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of a poster at the annual meeting of the National Lipid Association (NLA) further characterizing the efficacy and safety of Vascepa® (icosapent ethyl) in women with very high ...Amarin Gains 2% – Presents Poster on Vascepa For Women with Very High Triglyceride Levels (NASDAQ:AMRN)Sonoran Weekly ReviewVascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With ...SYS-CON Media (press release)all 3 news articles »
05/20/16 07:16 PMAmarin : Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With Very High Triglyceride Levels - BEDMINSTER, NJ and DUBLIN, IRELAND-- (Marketwired) -- 05/20/16-- Amarin Corporation plc (NASDAQ: AMRN) today announced the presentation ... Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of ...
05/20/16 02:10 PMCompany Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Poster Presentation at National Lipid ... - Smarter Analyst - Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Poster Presentation at National Lipid ...Smarter AnalystAmarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of a poster at the annual meeting of the National Lipid Association (NLA) further characterizing the efficacy and safety of Vascepa® (icosapent ethyl) in women with very high ...and more »
05/20/16 10:03 AMVascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With Very High Triglyceride Levels - [at noodls] - May 20, 2016 BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 05/20/16 -- Amarin Corporation plc(NASDAQ: AMRN)today announced the presentation of a poster at the annual meeting of the National Lipid ...
05/20/16 09:51 AM10:51 am Amarin announces presentation further characterizing the efficacy and safety of Vascepa in women with very high triglyceride levels -
05/18/16 02:08 PMRevenue Update on Amarin Corporation plc (ADR)(NASDAQ:AMRN) - Trade Calls - Revenue Update on Amarin Corporation plc (ADR)(NASDAQ:AMRN)Trade CallsAmarin Corporation plc (ADR)(NASDAQ:AMRN) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 5, 2016. Company reported revenue of $25.54M. Analysts estimated a revenue of $26.77M. Earnings ...Amarin Corporation PLC (AMRN) Updated Broker Price TargetsShare Trading NewsCurrent Price Targets For Amarin Corporation PLC (AMRN)Risers & FallersInvestors Checklist Stocks: Amarin Corporation PLC (NASDAQ:AMRN) , Prothena Corporation plc (NASDAQ:PRTA)Street UpdatesInvestor Newswireall 10 news articles »
05/16/16 07:05 AMHC Stocks in Hub: Valeant Pharmaceuticals Intl Inc (VRX), Amarin Corporation plc (AMRN), Inovio Pharmaceuticals Inc ... - share market updates (press release) - HC Stocks in Hub: Valeant Pharmaceuticals Intl Inc (VRX), Amarin Corporation plc (AMRN), Inovio Pharmaceuticals Inc ...share market updates (press release)Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ended Friday session in green amid volatile trading. The shares closed up +0.98 points or 3.93% at $25.91 with 33.87 million shares getting traded. Post opening the session at $25.09, the shares hit ...and more »
05/15/16 02:19 PMAfter Last Week What Do Analysts Think Of Amarin Corporation PLC (AMRN) - Share Trading News - After Last Week What Do Analysts Think Of Amarin Corporation PLC (AMRN)Share Trading News10/17/2013 – Amarin Corporation PLC was downgraded to “neutral” by analysts at JP Morgan. The share price of Amarin Corporation PLC (AMRN) was up +3.87% during the last trading session, with a day high of 1.66. 652222 shares were traded on Amarin ...
05/13/16 02:18 PMHC Stocks Vigilant: Inovio Pharmaceuticals Inc (INO), Amarin Corporation plc (AMRN), Allergan plc (AGN) - share market updates (press release) - HC Stocks Vigilant: Inovio Pharmaceuticals Inc (INO), Amarin Corporation plc (AMRN), Allergan plc (AGN)share market updates (press release)Amarin Corporation plc (ADR) (AMRN) announced that new data related to Vascepa® (icosapent ethyl) and eicosapentaenoic acid (EPA) will be presented at the upcoming National Lipid Association 2016 Scientific Sessions in New Orleans (May 19-22).and more »
05/12/16 07:23 PMVascepa And EPA Findings To Be Announced At National Lipid Association 2016 Scientific Sessions By Amarin Corporation (NASDAQ:AMRN) - Amarin Corporation plc (ADR) (NASDAQ:AMRN) will give a presentation on their new findings ... enough to disclose only information that is truthful and not misleading. The company has also been allowed to use the results of their clinical trials in their ...
05/12/16 02:18 PMHC Stocks in Focus: Pacific Biosciences of California (PACB), Amarin Corporation plc (AMRN), Arrowhead ... - share market updates (press release) - HC Stocks in Focus: Pacific Biosciences of California (PACB), Amarin Corporation plc (AMRN), Arrowhead ...share market updates (press release)Shares of Pacific Biosciences of California (NASDAQ:PACB) ended Wednesday session in green amid volatile trading. The shares closed up +0.23 points or 2.60% at $9.08 with 1.39 million shares getting traded. Post opening the session at $8.79, the shares ...and more »
05/11/16 06:30 AMVascepa(R) (icosapent ethyl) and Eicosapentaenoic Acid (EPA) Data to Be Presented at National Lipid Association 2016 Scientific Sessions - [Marketwired] - Amarin Corporation plc today announced that new data related to Vascepa® and eicosapentaenoic acid will be presented at the upcoming National Lipid Association 2016 Scientific Sessions in New Orleans ...
05/10/16 02:18 PM8 Biotechnology Stocks to Buy Now - Investorplace.com - 8 Biotechnology Stocks to Buy NowInvestorplace.comExelixis, Inc.'s (EXEL) ratings are looking better this week, moving up to a A from last week's B. Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment ...and more »
05/09/16 02:18 PMEarnings Overview of the Stock: Amarin Corporation plc (ADR) (NASDAQ:AMRN) - News Oracle - News OracleEarnings Overview of the Stock: Amarin Corporation plc (ADR) (NASDAQ:AMRN)News OracleLast Trade: The Company fell -7.88% and finished at $1.52. The daily volume was measured at 1.49 million shares. The 52-week high of the share price is $2.80 and the 52-week low is $1.24. The company has a market cap of $256.38 million. Its latest ...and more »
05/09/16 02:18 PMHC Stocks Recent Updates: XOMA Corp (XOMA), Amarin Corporation plc (AMRN), Teva Pharmaceutical Industries Ltd ... - share market updates (press release) - share market updates (press release)HC Stocks Recent Updates: XOMA Corp (XOMA), Amarin Corporation plc (AMRN), Teva Pharmaceutical Industries Ltd ...share market updates (press release)Shares of XOMA Corp (NASDAQ:XOMA) ended Friday session in red amid volatile trading. The shares closed down -0.017 points or -2.34% at $0.723 with 922,104.00 shares getting traded. Post opening the session at $0.77, the shares hit an intraday low of ...and more »
04/04/16 06:07 AMNew Clinical and Pre-Clinical Data Presented at American College of Cardiology Meeting on the Effect of EPA Therapy in Statin-Treated Patients and on Endothelial Function in Exploratory Studies - [at noodls] - April 4, 2016 BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 04/04/16 -- Amarin Corporation plc(NASDAQ: AMRN)today announced two posters presented yesterday at the annual meeting of the American ...
About Amarin Co. plc

Amarin Co. plc logoAmarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The Company operates in the business segment of development and commercialization of Vascepa. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its Distributors, that in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers. The Company markets Vascepa in the United States.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AMRN
  • CUSIP:
Key Metrics:
  • Previous Close: $2.10
  • 50 Day Moving Average: $1.94
  • 200 Day Moving Average: $1.70
  • P/E Ratio: N/A
  • P/E Growth: -0.02
  • Market Cap: $368.88M
  • Current Quarter EPS Consensus Estimate: $-0.49 EPS
Additional Links:
Amarin Co. plc (NASDAQ:AMRN) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha